Use of Nintendo Wii Fit™ in the rehabilitation of outpatients following total knee replacement: a preliminary randomised controlled trial

V Fung, A Ho, J Shaffer, E Chung, M Gomez - Physiotherapy, 2012 - Elsevier
OBJECTIVES: To determine whether Nintendo Wii Fit™ is an acceptable adjunct to
physiotherapy treatment in the rehabilitation of balance, lower extremity movement, strength …

Pharmacotherapy for spinal muscular atrophy in babies and children: a review of approved and experimental therapies

CA Chiriboga - Pediatric Drugs, 2022 - Springer
Spinal muscular atrophy (SMA) is an autosomal recessive degenerative neuromuscular
disorder characterized by loss of spinal motor neurons leading to muscle weakness and …

The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?

R Lachmann, B Schoser - Orphanet journal of rare diseases, 2013 - Springer
Pompe disease/glycogen storage disease type II, is a rare, lysosomal storage disorder
associated with progressive proximal myopathy, causing a gradual loss of muscular function …

Motor function measure: validation of a short form for young children with neuromuscular diseases

C De Lattre, C Payan, C Vuillerot, P Rippert… - Archives of physical …, 2013 - Elsevier
Objective To validate a useful version of the Motor Function Measure (MFM) in children with
neuromuscular diseases aged< 7 years old. Design Two prospective cohort studies that …

Responsiveness of the motor function measure in patients with spinal muscular atrophy

C Vuillerot, C Payan, J Iwaz, R Ecochard… - Archives of physical …, 2013 - Elsevier
Objective To assess the ability of the Motor Function Measure (MFM) to detect changes in
the progression of spinal muscular atrophy (SMA). Design Observational, retrospective …

Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne muscular dystrophy: an observational multicenter trial

AM Seferian, A Moraux, M Annoussamy, A Canal… - PLoS …, 2015 - journals.plos.org
Introduction Upper limb evaluation of patients with Duchenne Muscular Dystrophy is
crucially important to evaluations of efficacy of new treatments in non-ambulant patients. In …

SELENON-related myopathy across the life span, a cross-sectional study for preparing trial readiness

K Bouman, JT Groothuis, J Doorduin… - Journal of …, 2023 - journals.sagepub.com
Background: SELENON (SEPN1)-related myopathy (SELENON-RM) is a rare congenital
neuromuscular disease characterized by proximal and axial muscle weakness, spinal …

A cross-sectional study of nemaline myopathy

K Amburgey, M Acker, S Saeed, R Amin, AH Beggs… - Neurology, 2021 - AAN Enterprises
Objective Nemaline myopathy (NM) is a rare neuromuscular condition with clinical and
genetic heterogeneity. To establish disease natural history, we performed a cross-sectional …

Hammersmith functional motor scale and motor function measure-20 in non ambulant SMA patients

E Mazzone, R De Sanctis, L Fanelli, F Bianco… - Neuromuscular …, 2014 - Elsevier
The aim of this prospective longitudinal multi centric study was to evaluate the correlation
between the Hammersmith Functional Motor Scale and the 20 item version of the Motor …

Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis

S Schmidt, P Hafner, A Klein, D Rubino-Nacht… - Neuromuscular …, 2018 - Elsevier
The development of new therapeutic agents for the treatment of Duchenne muscular
dystrophy has put a focus on defining outcome measures most sensitive to capture treatment …